CORT
Corcept Therapeutics Incorporated
116.20$
+1.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -7,904.1% | -2,274.7% | -8,785.6% | -61,958.6% | – | – | -1,089.2% | -357.8% | -103.1% | 6.2% | 22.6% | 38.3% | 46.0% | 44.4% | 42.9% | 45.9% | 29.9% | 26.3% | 29.3% | 18.6% | |
| – | – | – | – | – | 4.8% | 2.7% | 5.7% | 34.5% | – | – | 0.8% | 0.7% | 0.5% | 0.3% | 0.1% | 0.1% | 0.1% | 0.7% | 0.6% | 0.8% | 0.9% | 0.5% | 0.2% | 0.2% | |
| – | – | – | – | – | – | 219.9% | 777.0% | 6,203.4% | – | – | 160.6% | 50.2% | 19.6% | 12.0% | 8.7% | 8.4% | 9.5% | 9.6% | 9.5% | 11.7% | 10.6% | 10.1% | 9.1% | 11.1% | |
| – | – | – | – | – | – | – | – | – | – | – | 160.6% | 50.2% | 19.6% | 12.0% | 8.7% | -39.6% | 15.1% | 15.1% | 13.5% | 12.9% | 2.5% | – | – | – | |
| – | – | – | – | – | 23.1% | -96.3% | -584.7% | 1,286.2% | – | – | -151.4% | -7.4% | -19.0% | 1.0% | 1.4% | -3.6% | 1.6% | -1.5% | -1.5% | 0.0% | 1.4% | 1.7% | 6.7% | -3.6% | |
| – | – | – | – | – | 447.3% | 0.0% | 3.3% | 24.1% | – | – | 4.6% | 1.2% | 0.7% | 0.0% | 0.2% | 0.3% | 0.1% | 0.4% | 0.3% | 0.1% | 0.1% | 0.0% | 0.3% | 0.0% | |
| – | – | – | – | – | 8,626.2% | -1,116.2% | 1,114.4% | 12,393.1% | – | – | -4.6% | -1.2% | -0.7% | 0.0% | -0.2% | -46.1% | -36.1% | -38.4% | -33.7% | 37.2% | -28.4% | 18.8% | -26.3% | 9.2% | |
| – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 2.3% | 6.1% | 3.9% | 5.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 1,805.5% | 0.5% | 6.7% | 44.3% | 9.4% | 4.5% | -9.4% | -10.1% | -2.8% | -80.9% | -5.4% | -30.1% | -2.3% | -32.3% | |
| – | – | – | – | – | – | – | – | – | – | – | 902.9% | -9.9% | -18.3% | -18.3% | -18.2% | -9.5% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | 1,009.2% | 3,915.1% | 9,242.1% | 81,120.7% | – | – | 2,708.4% | -9.4% | -11.6% | 26.0% | -8.7% | -5.0% | -5.7% | -9.3% | 3.5% | -82.7% | -4.3% | -30.8% | -4.2% | -28.9% | |
| – | – | – | – | – | 1,731.3% | 524.3% | 1,570.8% | 31,555.2% | – | – | 1,614.7% | -368.4% | -115.4% | 32.2% | 13.7% | -12.9% | 4.2% | -3.4% | 12.7% | 0.4% | -2.8% | 14.4% | -1.2% | -0.9% | |
| – | – | – | – | – | -8,351.4% | -2,274.7% | -8,789.0% | -61,982.8% | – | – | -1,093.8% | -359.0% | -103.8% | 6.2% | 22.4% | 38.0% | 45.9% | 44.1% | 42.6% | 45.7% | 29.8% | 26.3% | 29.0% | 18.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.